Clinical Trial Update: A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating capecitabine with concomitant radiation therapy for newly diagnosed pediatric brainstem gliomas; results were posted after completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brainstem Glioma

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Brainstem Glioma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-03